Commonly utilized pain and epilepsy drug, Pregabalin, may increase risk of birth defects such as heart and central nervous system problems.
Browsing: adverse effects
New findings have indicated a potential link between mitoxantrone and an increased risk of colorectal cancer.
New research demonstrates that electrical stimulation of deep midbrain structures blocks pain signals in the spinal cord of rats, indicating a possible new direction for the treatment of chronic pain.
Researchers call for bone health to be monitored in children receiving treatment for attention deficit hyperactivity disorder after potential link with low bone density identified.
Selective serotonin reuptake inhibitors (SSRIs) are not associated with an increased risk of cardiovascular disease, a new study has shown.
New results have indicated that the risk of stroke associated with untreated arteriovenous malformations now outweighs concerns over undergoing Gamma Knife radiosurgery.
This article discusses a major sodium ion channel termed Nav1.7 that has been identified in humans as essential for pain detection, considering strategies for targeting the channel as a potential alternative to opiates and other short acting pain killers with often significant adverse effects.
New orphan drug designation for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease
A small molecule inhibitor, termed dipraglurant, has been granted orphan drug designation for Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease by the US FDA.
New study highlights potential technique for reducing adverse side effects in Alzheimer’s Disease immunotherapy.
This review discusses the evidence linking arterial stiffness, hypertension and brain structural abnormalities in older adults.